We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
51.53%
This Fund
S&P 500
This Quarter
Est. Return
+4.63%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+1,172.21%
AUM
$77.1B
AUM Growth
-$1.68B
(-2.1%)
Cap. Flow
-$2.68B
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
3,716
New
704
Increased
979
Reduced
1,056
Closed
911
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$626M |
| 2 |
Warner Bros
WBD
|
+$447M |
| 3 |
Apple
AAPL
|
+$436M |
| 4 |
RTX Corp
RTX
|
+$434M |
| 5 |
Constellation Brands
STZ
|
+$320M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.13B |
| 2 |
Microsoft
MSFT
|
+$502M |
| 3 |
RNAM
Avidity Biosciences
RNAM
|
+$436M |
| 4 |
EXAS
Exact Sciences
EXAS
|
+$415M |
| 5 |
EA
Electronic Arts
EA
|
+$388M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.75% |
| 2 | Industrials | 9.36% |
| 3 | Consumer Discretionary | 8.52% |
| 4 | Healthcare | 7.75% |
| 5 | Financials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
DexCom
DXCM
$33.9B
| $35.6M | 0.05% |
566,312
-448,534
| -44% | -$31.2M |
|
452
Planet Fitness
PLNT
$3.8B
| $35.5M | 0.05% |
477,593
-130,523
| -21% | -$11.5M |
|
453
WEX
WEX
$6.54B
| $35.5M | 0.05% |
+231,924
| New | +$36.3M |
|
454
Liberty Media Series C
FWONK
$26B
| $35.2M | 0.05% |
414,164
-196,790
| -32% | -$17.2M |
|
|
CTRA
455
CALL
DELISTED
Coterra Energy
CTRA
| $35.1M | 0.05% |
1,000,000
+946,800
| +1,780% | +$28.5M |
|
456
Columbia Banking Systems
COLB
$9.25B
| $35.1M | 0.05% |
1,280,063
-2,508,894
| -66% | -$72.5M |
|
457
Ralph Lauren
RL
$23.2B
| $34.9M | 0.05% |
101,579
-100,821
| -50% | -$35.8M |
|
458
Viper Energy
VNOM
$15.2B
| $34.5M | 0.04% |
734,759
-6,414
| -0.9% | -$275K |
|
459
Twist Bioscience
TWST
$7.44B
| $34.5M | 0.04% |
726,288
+146,918
| +25% | +$6.59M |
|
460
PUT
Argan
AGX
$8.11B
| $34.4M | 0.04% |
+63,200
| New | +$25.8M |
|
461
AptarGroup
ATR
$8.4B
| $34.2M | 0.04% |
271,589
+184,880
| +213% | +$24.1M |
|
462
Stryker
SYK
$130B
| $34.2M | 0.04% |
103,993
+97,888
| +1,603% | +$35.1M |
|
463
Hubbell
HUBB
$27B
| $34M | 0.04% |
69,219
+67,058
| +3,103% | +$32.9M |
|
464
CALL
iShares Silver Trust
SLV
$31.5B
| $33.9M | 0.04% |
498,100
-156,800
| -24% | -$11.9M |
|
|
CNTA
465
DELISTED
Centessa Pharmaceuticals
CNTA
| $33.9M | 0.04% |
852,828
+384,013
| +82% | +$9.82M |
|
|
MANE
466
Veradermics Inc
MANE
$4.71B
| $33.7M | 0.04% |
+532,906
| New | +$26.9M |
|
467
CALL
Rivian
RIVN
$22.2B
| $33.6M | 0.04% |
2,230,700
-456,500
| -17% | -$7.3M |
|
468
PUT
AT&T
T
$171B
| $33.6M | 0.04% |
1,157,400
+1,035,700
| +851% | +$27.7M |
|
469
Ventas
VTR
$46.9B
| $33.5M | 0.04% |
409,049
+331,083
| +425% | +$27.1M |
|
470
Compass
COMP
$9.99B
| $33.4M | 0.04% |
+4,565,713
| New | +$48M |
|
471
Atlantic Union Bankshares
AUB
$6.12B
| $33.3M | 0.04% |
930,726
+324,349
| +53% | +$12.2M |
|
472
Cogent Biosciences
COGT
$6.58B
| $33M | 0.04% |
856,598
-583,720
| -41% | -$21.6M |
|
|
473
CALL
Microsoft
MSFT
$3.68T
| $32.9M | 0.04% |
88,800
-64,700
| -42% | -$27.1M |
|
|
SNCY
474
DELISTED
Sun Country Airlines
SNCY
| $32.6M | 0.04% |
1,973,514
+1,930,214
| +4,458% | +$34.5M |
|
475
SentinelOne
S
$7.92B
| $32.5M | 0.04% |
2,526,375
+2,082,081
| +469% | +$28.9M |
|
Similar funds
RIM
Balyasny Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Balyasny Asset Management held 3,716 positions worth $77.1B, down 2.1% from $78.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Balyasny Asset Management withdrew a net $2.68B in Q1 2026, closing 911 positions and reducing 1,056 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.13B position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in Silicon Laboratories worth $257M.
- Balyasny Asset Management's largest Q1 2026 buy was Silicon Laboratories: 1,233,893 shares worth $257M.
- Balyasny Asset Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $626M increase.
- Balyasny Asset Management's biggest Q1 2026 reduction was Microsoft, cutting an estimated $502M.
- Balyasny Asset Management fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.13B.
- Balyasny Asset Management's ten largest holdings make up 17% of its $77.1B portfolio in Q1 2026.
- Balyasny Asset Management opened 704 new positions and closed 911 in Q1 2026.
- Balyasny Asset Management's portfolio value fell 2.1% quarter-over-quarter to $77.1B.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.